Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report
Alcidion Group Limited (ASX:ALC) announced on Monday that it has signed a new contract with University Hospitals Sussex NHS Foundation Trust (UHSussex) to deploy its flagship Miya Precision platform as UHSussex's new Electronic Patient Record (EPR) system. The stock rose 1.82% to A$0.11 in …
Shares of Pacific Edge Limited (ASX:PEB) moved higher following the release of its audited FY26 financial results, as investors weighed a continued revenue decline against a significant regulatory and reimbursement development in the United States healthcare system.
The S&P/ASX 200 Health Care Index (ASX: XHJ) moved lower on Friday, falling 0.44% to 22,839.0 by 2:24pm AEST, as investor appetite shifted towardMiningandCommodity-linked sectors while healthcare names underperformed the broader Australian market.
According to the ASX announcement dated 22 May 2026, the receipt of these funds reinforces the Company’s significant and ongoing commitment to the development of differentiated cannabinoid formulations for pharmaceutical registration.
ASX Compliance issued the trading halt notice at the request of Nexalis. According to the ASX release, the securities will remain in trading halt until the earlier of the commencement of normal trading on Tuesday 26 May 2026 or the release of the announcement …
Mayne Pharma Group Ltd (ASX:MYX) shares moved higher during afternoon trade on 22 May 2026, with the stock climbing 4.24% to AUD 2.46 after the company released an update regarding legal proceedings involving Cosette Pharmaceuticals, Inc. Investor attention appeared to focus on the Court’s …
OncoSil Medical Ltd (ASX:OSL) shares rose 3.92% to AUD 0.53 on 22 May 2026 after the company announced that clinical data relating to its OncoSil™ device had been accepted for presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting 2026 in Chicago.
Oceania Healthcare Ltd (ASX:OCA) shares moved higher during the morning session on 22 May 2026, gaining 3.64% to AUD 0.57 after the retirement village and aged care operator released its audited full-year FY26 results.
Imugene Ltd (ASX:IMU) shares surged to AUD 0.115 on 22 May 2026, marking a sharp intraday gain of nearly 20% as investors reacted to newly released clinical data from its Azer-cel program presented at ASCO 2026. The move followed publication of an abstract highlighting …
Vitrafy Life Sciences Ltd (ASX:VFY) shares moved higher during the morning session on 22 May 2026, gaining 6.84% to AUD 2.50 after the company released final Phase II platelet cryopreservation results from its study conducted with the United States Army Institute of Surgical Research …
Please wait processing your request...
You are not subscribed for this report, Want to See?
One of our sales representative will contact you soon!
Welcome to Kalkine!
Start Your 7-Days Free Trial Today!
Hi! How can we help you today?
Loading…